Proport Invest är ett svenskt, onoterat investeringsbolag som fokuserar på entreprenörsledda bolag m...
Redeye provides an in-depth review of AcouSort’s Q1 report and events during and after the quarter.
Xoma är en svensk teknikleverantör som utvecklar landbaserade system för algodling och rening av pro...
So far, 2025 has turned out to be a very intense period, including a SEK 23m fundraising, publicatio...
Solwers posted a weak Q1, with revenue largely in line with our expectation but profitability clearl...
Redeye provides a research update following MindArk’s softer-than-expected Q1 report.
Redeye comments on the positive phase I results for IRL757 announced by IRLAB.
Redeye comments on Verve Group’s Q1 2025 results, which were in line with expectations in terms of t...
Solwers reported its results for Q1 (condensed business review) with sales of EUR 20.
Redeye comments on SynAct's Q1 report, which includes the initiation of a new phase II study in Deng...
Chordate Medical redovisade ökad nettoomsättning och minskad rörelseförlust i det första kvartalet.
Redeye comments on Klaria’s announcement earlier today regarding a SEK9.
2025 has turned out to be a very intense period so far, including a SEK 23m fundraising, publication...
Hansa Biopharma plans to restructure the organisation to optimise resource allocation and improve op...
Redeye comments on Lipigon’s first quarter report 2025.
